Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Trial of Gilead’s potential coronavirus treatment running ahead of schedule – researcher
Preliminary findings from the randomized trial of the antiviral drug remdesivir, begun in February by the National Institute of…
Getting Smart with Femtech: Take Advantage of this Market Potential
Siddharth Shah, Program Manager, Transformational Health, Frost & Sullivan writes about several initiatives that the…
China approves third COVID-19 vaccine for clinical trials
A total of 96 persons in three age groups have received the vaccine in the first phase of clinical trial as of April 23
“China’s recovery will largely depend on how the world perceives China right now”
Suresh Pareek, Managing Director, Ideal Cures tells Viveka Roychowdhury that though their US expansion will be on hold currently…
Jubilant Life Sciences contributes Rupees 5 Crores to the PM Cares fund
The contribution of Jubilant Life Sciences, along with all its subsidiaries, includes one day gross salary of its 5300 employees
COVID-19: FDA warns against side effects of hydroxychloroquine
The FDA in a Drug Safety Communication said that hydroxychloroquine has been given Emergency Use Authorisation for the treatment…
Striving for Global Domination by Indian Pharma
As the pharma sector across the globe is transforming and with new players joining the generics market, India will have to adopt a…
Natco Pharma gets EIR from USFDA for Telangana facility
USFDA had conducted pre-approval inspection at Natco’s facility in Kothur village from March 2-6, 2020
IPA requests PM to allow pharmacists to conduct COVID-19 tests and offer other services
IPA has also requested the government to acknowledge the role of pharmacists in the fight against COVID-19
IICT, LAXAI LifeSciences collaborate for key pharma intermediates
The collaboration will primarily focus on umifenovir, remdesivir and a key intermediate of hydroxychloroquine